References
- Coon WW. Venous thromboembolism: prevalence, risk factors and prevention. Clin Chest Med 1984;5:391-401.
- In KH. The national survery of acute pulmonary thromboembolism in Korea. Tuberc Respir Dis 2003;54:5-14.
- Kwaan HC, Wang J. Hyperviscosity in polycythemia vera and other red cell abnormalities. Semin Thromb Hemost 2003;29:451-458. https://doi.org/10.1055/s-2003-44552
- Michiels JJ, Berneman Z, Shcroyens W, Finazzi G, Budde U, van Viet HH. The paradox of platelet activation and impaired function; platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Semin Thromb Hemost 2006;32;589-604. https://doi.org/10.1055/s-2006-949664
- Cines DB, McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 2005;56:425-442. https://doi.org/10.1146/annurev.med.56.082103.104644
- Kang KS, Park JM, Yoon BW. Cerebral infarction associated with idiopathic thrombocytopenic purpura. J Korean Neurol Assoc 2006;24:605-607.
- Kim JH, Park KU, Chun WJ, Kim SH, Nah DY. Primary percutaneous coronary intervention for acute myocardial infarction with idiopathic thrombocytopenic purpura. J Korean Med Sci 2006;21:355-357.
- Paolini R, Fabris F, Cella G. Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP). Am J Hematol 2000;65:177-178. https://doi.org/10.1002/1096-8652(200010)65:2<177::AID-AJH17>3.0.CO;2-K
- Fruchter O, Blich M, Jacob G. Fatal acute myocardial infarction during severe thrombocytopenia in a patient with idiopathic thrombocytopenic purpura. Am J Med Sci 2002;323:279-280. https://doi.org/10.1097/00000441-200205000-00010
- Pierrot-Deseilligny Despujol C, Michel M, Khellaf M, et al. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Br J Haematol 2008;142:638-643. https://doi.org/10.1111/j.1365-2141.2008.07228.x
- Diz-Kucukkaya R, Hacihanefioglu A, Yenerel M, et al. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood 2001;98:1760-1764. https://doi.org/10.1182/blood.V98.6.1760
- Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-1311. https://doi.org/10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
- Kravitz MS, Shoenfeld Y. Thrombocytopenic conditions-autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS. Am J Hematol 2005;80:232-242. https://doi.org/10.1002/ajh.20408
- Asherson RA, Gunter K, Daya D, Shoenfeld Y. Multiple autoimmune disease in a young woman: tuberculosis and splenectomy as possible triggering factors? Another example of the "mosaic" of autoimmunity. J Rheumatol 2008;35:1224-1226.
- Zonana MF, Reyes E, Weisman AK. Coexistence of four autoimmune disease in one patient: the kaleidoscope of autoimmunity. J Clin Rheumatol 2002;8:322-325. https://doi.org/10.1097/00124743-200212000-00008
- Woo TW, Kim BH, Shim JJ, Kim YH, Cho KS. A case of primary cirrhosis manifestated with idiopathic thrombocytopenic purpura and Sjoren's syndrome. Korean K Med 2004;66:80-85.
- Levene NA, Varon D, Shtalrid M, Berrebi A. Chronic active hepatitis following splenectomy for autoimmune thrombocytopenia. Isr J Med Sci 1991;27:199-201.
- Ruffatti A, Del Ross T, Ciprian M, et al. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a multicentre, retrospective follow-up study. Ann Rheum Dis 2009;68:397-399. https://doi.org/10.1136/ard.2008.096669
- Iwahara Y, Niiya K, Yamato K, Miyoshi I. Thrombocytopenic purpura in a patient with lupus anticoagulant: requirement of both immunosuppressive and antithrombotic therapies. Am J Hematol 1990;33:75-77. https://doi.org/10.1002/ajh.2830330116